2023年6月6日

06/06/2023 | 04:12pm信息:美国东部时间1934年证券交易法的报告日期(日期最早的事件报道):5月31日,2023年频率疗法,INC .特拉华州列克星敦,MA02421 (781) 315 - 4600 N / A(前名或前地址,如果改变了自去年报告)检查适当的框下面如果表单8-Kfiling是为了同时满足申请注册人有下列规定的义务(见下面的总论A):☐☐☐☐证券注册依照12节(b)的行为:每个类的频率纳斯达克股票市场公司(纳斯达克全球精选市场)显示复选标记是否定义的注册人是一家新兴公司在1933年的证券法案405规则(§230.405本章)或规则12 b-2of 1934年证券交易法(§240.12 b-2of本章)。新兴公司☒如果一个新兴公司,表明通过复选标记如果注册人当选不使用扩展的过渡期间,遵守任何新的或修改后的财务会计准则提供依照第13节(a)的交换行为。☐2.05项。相关成本退出或处置活动5月31日,2023年,频率疗法,Inc .(以下简称“公司”)宣布了一项减少力的“减少”)(约55%的劳动力。减少的目的,是通过董事会(“董事会”)的公司在5月31日,2023年,是为了更好的使公司的劳动力与不断变化的业务需求。将在6月9日完成,减少2023。减少相关的总成本估计约116万美元在未来现金支出主要相关遣散费成本和相关费用。项目5.02离职董事或某些官员;选举董事的;某些官员的任命; Compensatory Arrangements of Certain Officers. On June 1, 2023, the Company and Richard Mitrano, Vice President of Finance and Operations and the Company's principal financial officer, entered into an amendment (the "Amendment") to a letter agreement between the Company and Mr. Mitrano regarding certain of his employment terms, dated October 10, 2019 (the "Employment Agreement"). The Amendment extends the severance period during which Mr. Mitrano will receive continued payment of his base salary in the event that his employment is terminated by the Company without cause or by him for good reason (a "qualifying termination") from six (6) months to nine (9) months. The Amendment also extends the severance period in the event of a qualifying termination during the twelve (12)-month period following a change in control from nine (9) months to twelve (12) months. Under the Employment Agreement and the Amendment, the Company will also pay the employer-portion of premiums for Mr. Mitrano's group health plan continuation coverage under the Consolidated Omnibus Budget Reconciliation Act ("COBRA") during the applicable severance period, subject to Mr. Mitrano's election of COBRA health continuation coverage, until he becomes eligible for group health plan coverage through other employment or the earlier termination of his COBRA continuation coverage period. The foregoing description is qualified in its entirety by the Amendment, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K andincorporated herein by reference. Item 9.01.